| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 93.201 | 84.556 | 49.580 | 37.908 | 55.769 | 122.088 | 85.819 | 79.103 | 336.386 | 319.554 |
| Total Income - EUR | 93.235 | 84.558 | 49.743 | 37.908 | 55.885 | 122.262 | 85.827 | 92.225 | 336.412 | 319.569 |
| Total Expenses - EUR | 96.221 | 86.343 | 54.381 | 47.408 | 36.822 | 98.532 | 98.846 | 109.673 | 303.040 | 301.388 |
| Gross Profit/Loss - EUR | -2.986 | -1.785 | -4.638 | -9.499 | 19.063 | 23.730 | -13.018 | -17.448 | 33.372 | 18.181 |
| Net Profit/Loss - EUR | -4.102 | -2.631 | -5.135 | -9.879 | 18.504 | 22.336 | -14.131 | -18.457 | 29.826 | 14.980 |
| Employees | 3 | 4 | 3 | 4 | 3 | 4 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Rts Start Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 197 | 100 | 67 | 565 | 336 | 24.991 | 19.169 | 1.387 | 1.084 | 1.416 |
| Current Assets | 24.987 | 23.446 | 20.530 | 18.814 | 44.557 | 66.173 | 33.827 | 85.564 | 148.736 | 86.554 |
| Inventories | 5.362 | 10.429 | 7.235 | 5.790 | 14.846 | 4.345 | 7.607 | 54.076 | 42.204 | 23.973 |
| Receivables | 14.993 | 9.044 | 12.796 | 12.362 | 29.190 | 53.365 | 23.216 | 22.447 | 94.746 | 56.508 |
| Cash | 4.632 | 3.974 | 499 | 662 | 521 | 8.462 | 3.003 | 9.041 | 11.785 | 6.073 |
| Shareholders Funds | 7.497 | 4.790 | -427 | -10.298 | 8.406 | 30.582 | 15.773 | -2.635 | 27.199 | 16.636 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.686 | 18.756 | 21.023 | 29.677 | 36.487 | 60.582 | 37.222 | 89.586 | 122.620 | 71.334 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Rts Start Pharm Srl